It's no secret that doctors are helping many people lose weight by prescribing GLP-1 medications like Ozempic, Wegovy, ...

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

Due to their rise in popularity over the last few years, you’ve probably heard the buzz around medications like Ozempic. GLP-1 agonist medications have gained significant attention, especially ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...

Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from ...

Drugs such as Wegovy, Ozempic, and Saxenda have quickly become household names. But are these weight loss medications right ...

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...

Furthermore, the cardiovascular benefits of Ozempic and Wegovy have been unveiled in the ... such benefits could also be a ...

Related: Celebrities Are Apparently Taking Ozempic, a Drug Intended for Diabetes, to Help Them Lose Weight Rapidly—But Is That Safe? GLP-1 agonists are a class of medications that mimic the ...

Furthermore, the cardiovascular benefits of Ozempic and Wegovy have been ... for drug reimbursement in the near future. "Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events ...